✦ LIBER ✦

Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension

✍ Scribed by N. Galie; A.L. Hinderliter; A. Trobicki; T. Fourme

Book ID: 114347630
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 35 KB
Volume: 12
Category: Article
ISSN: 1062-1458
DOI: 10.1016/s1062-1458(03)00262-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of the dual endothelin-receptor

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

✍ Richard N Channick; Gérald Simonneau; Olivier Sitbon; Ivan M Robbins; Adaani Fro 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 90 KB

Effects of the dual endothelin receptor

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study

✍ R. Channick; D.B. Badesch; V.F. Tapson; G. Simonneau; I. Robbins; A. Frost; S. R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Effects of the dual endothelin-receptor

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study

✍ R.N. Channick; G. Simonneau; O. Sitbon 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Long-term outcome and effects of oral bo

Long-term outcome and effects of oral bosentan therapy in Taiwanese patients with advanced idiopathic pulmonary arterial hypertension

✍ Hsao-Hsun Hsu; Jin-Shing Chen; Robert J. Chen; Wen-Je Ko; Shuenn-Wen Kuo; En-Tin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Improvement of vascular endothelial func

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis

✍ P. P. Sfikakis; C. Papamichael; K. S. Stamatelopoulos; D. Tousoulis; K. G. Fragi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Objective Increased endothelin activity may play a role in the pathogenesis of vascular injury, a primary feature of systemic sclerosis (SSc; scleroderma). Our goal was to test the hypothesis that treatment with the oral endothelin receptor antagonist bosentan might improve vascular

Effect of the dual endothelin receptor a

Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report

✍ Fátima Álvarez Reyes; Cristina Luna Gómez; Manuel Brito Suárez 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 670 KB